Shares of MacroGenics are surging in Thursday midday trading after the biotechnology company raised $80 million in its initial public offering.
MacroGenics sold 5 million shares of stock for $16 per share. It had expected to sell 4 million shares for $14 to $16 each. The $80 million total does not include expenses or underwriting discounts.